Target intelligence / Profile preview

N-methyl-D-aspartate receptor containing GluN2B subunit (NMDA receptor (GluN2B))

Target
NMDA receptor (GluN2B)
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor (glutamate receptor), Transmembrane protein
01

Overview

The N-methyl-D-aspartate receptor containing GluN2B subunit is a heteromeric, ligand-gated ion channel critical for excitatory synaptic transmission in the brain. The GluN2B-containing NMDA receptor is one of several receptor subtypes arising from variable subunit composition (two GluN1 and typically two GluN2, of which GluN2B is one variant, possibly joined by GluN2A or GluN3). This receptor permits calcium, sodium, and potassium ion flow upon simultaneous binding of glutamate and glycine or D-serine and appropriate postsynaptic depolarization to relieve its Mg^2+^ block. The GluN2B subunit governs several key properties including channel conductance, sensitivity to magnesium and zinc, kinetics of activation/deactivation, and allosteric modulator response (e.g., to ifenprodil). Functionally, this receptor is crucial for synaptic plasticity, learning, memory formation, and neurodevelopment; it is also strongly implicated in a range of neurological diseases. Selective antagonism of GluN2B NMDA receptors is being pursued as a therapeutic approach in neurodegenerative and neuropsychiatric diseases, but safety and efficacy remain major concerns due to the receptor’s essential physiological role.

Other names
NMDA receptor GluN2B subunitNR2B (historical)GluN2B (current IUPHAR nomenclature)NMDAR (with GluN2B composition)
02

Mechanism of action

Noncompetitive antagonism at the channel pore (memantine, ketamine, MK-801); Allosteric inhibition via the amino-terminal domain (Ifenprodil, Ro 25-6981); Channel blockage via voltage-dependent Mg^2+^ binding

03

Biological functions

Excitatory neurotransmission in the central nervous systemSynaptic plasticity (including long-term potentiation)Learning and memory formationRegulation of dendritic spine density and actin cytoskeletonMediates Ca^2+^ entry and intracellular signaling
04

Disease associations

Neurodegenerative disease (Alzheimer's disease, Parkinson's disease, Huntington's disease)Cognitive disorders (learning and memory impairment)Pain and nociceptionOther CNS disorders (epilepsy, schizophrenia, depression)
05

Safety considerations

Potential for neurotoxicity/excitotoxicity with excessive inhibition/activationCognitive adverse effects (memory impairment, dissociation)Psychotomimetic effects (e.g., with ketamine)Difficulties in achieving subunit-selectivity (off-target effects on non-GluN2B NMDA receptors)
06

Interacting drugs

Memantine

5 more in the full profile.

07

Biomarkers

GluN2B protein expression levels (immunohistochemistry, Western blot)Altered synaptic plasticity markers (e.g., long-term potentiation, dendritic spine density)PSD-95 (postsynaptic density protein 95) association

Beyond the preview

Go deeper on N-methyl-D-aspartate receptor containing GluN2B subunit (NMDA receptor (GluN2B)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-methyl-D-aspartate receptor containing GluN2B subunit (NMDA receptor (GluN2B)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call